Royalty Pharma plc Overview
Royalty Pharma plc Target Price
Analysts' 12-month price predictions for RPRX.
Get informed when a big investor buys or sells
+ FollowShare Price
$55.34
Average Target Price
$56.67
2.4% upside
2.4% upside3 analysts in the last 4 months
High: $63 | Low: $50
Analyst Recommendations
No recommendations in the last 4 months.
Revenue & Income Forecast
Analysts' Target Prices
| Date | Analyst | Price Target | Current Upside/Downside | |
|---|---|---|---|---|
| 2026-04-21 | UBSAshwani Verma | $57 | 3% upside |  |
| 2026-04-10 | Morgan StanleyTerence Flynn | $63 | 13.8% upside | |
| 2026-02-27 | Seaport Global | $50 |  9.6% downside | |
| 2026-02-12 | Morgan StanleyTerence Flynn | $61 | 10.2% upside | |
| 2026-01-30 | UBSAshwani Verma | $49 | 11.5% downside | |
| 2025-12-11 | Leerink Partners | $45 | 18.7% downside | |
| 2025-09-30 | Goldman Sachs | $42 | 24.1% downside | |
| 2025-07-10 | Morgan StanleyTerence Flynn | $54 | 2.4% downside | |
| 2024-09-04 | Goldman SachsChris Shibutani | $51 | 7.8% downside | |
| 2024-07-11 | Morgan StanleyTerence Flynn | $51 | 7.8% downside | |
| 2024-06-07 | Goldman SachsChris Shibutani | $50 | 9.6% downside | |
| 2024-06-03 | UBSAshwani Verma | $28 | 49.4% downside | |
| 2022-12-06 | Morgan Stanley | $51 | 7.8% downside | |
| 2022-06-13 | UBSAshwani Verma | $47 | 15.1% downside | |